JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.19B |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$680M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$663M |
| 5 |
SLB Ltd
SLB
|
+$522M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$2.45B |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$1.03B |
| 3 |
McKesson
MCK
|
+$941M |
| 4 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$875M |
| 5 |
Coca-Cola
KO
|
+$711M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.37% |
| 2 | Financials | 13.44% |
| 3 | Technology | 11.39% |
| 4 | Healthcare | 10.14% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
Cintas
CTAS
$81.8B
| $47.5M | 0.01% |
1,687,604
-259,668
| -13% | -$7.11M |
2013 Q2
13 quarters
|
|
852
DELISTED
Exact Sciences
EXAS
| $47.3M | 0.01% |
2,549,123
-236,868
| -9% | -$4.17M |
2013 Q2
13 quarters
|
|
853
State Street SPDR S&P Biotech ETF
XBI
$10B
| $47.3M | 0.01% |
712,986
-1,633,237
| -70% | -$101M |
2013 Q2
13 quarters
|
|
854
CALL
Axalta
AXTA
$7.01B
| $46.9M | 0.01% |
1,659,121
| – | – |
2016 Q2
1 quarter
|
|
|
855
PUT
Axalta
AXTA
$7.01B
| $46.9M | 0.01% |
1,659,121
| – | – |
2016 Q2
1 quarter
|
|
|
IPHI
856
DELISTED
INPHI CORPORATION
IPHI
| $46.9M | 0.01% |
1,077,115
-53,944
| -5% | -$2.08M |
2013 Q2
13 quarters
|
|
|
APU
857
DELISTED
AmeriGas Partners, L.P.
APU
| $46.8M | 0.01% |
1,025,148
-44,438
| -4% | -$2.08M |
2013 Q2
13 quarters
|
|
858
Liberty Global Class A
LBTYA
$2.92B
| $46.6M | 0.01% |
1,363,319
+254,966
| +23% | +$8.1M |
2013 Q2
13 quarters
|
|
|
HK
859
DELISTED
Halcon Resources Corporation
HK
| $46.5M | 0.01% |
+4,961,293
| New | +$58.2M |
2016 Q3
0 quarters
|
|
860
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $46.5M | 0.01% |
577,000
-172,400
| -23% | -$14.1M |
2014 Q3
8 quarters
|
|
|
CYS
861
DELISTED
CYS Investments Inc.
CYS
| $46.2M | 0.01% |
5,303,719
+42,442
| +0.8% | +$374K |
2013 Q2
13 quarters
|
|
|
GG
862
DELISTED
Goldcorp Inc
GG
| $46M | 0.01% |
2,781,695
-413,138
| -13% | -$7.28M |
2013 Q2
13 quarters
|
|
863
COPT Defense Properties
CDP
$3.82B
| $45.9M | 0.01% |
1,620,266
+621,890
| +62% | +$18M |
2013 Q2
13 quarters
|
|
864
DELISTED
Instructure, Inc.
INST
| $45.8M | 0.01% |
1,806,228
+260,990
| +17% | +$6.02M |
2015 Q4
3 quarters
|
|
865
CALL
Alphabet (Google) Class A
GOOGL
$4.3T
| $45.2M | 0.01% |
1,124,380
+30,300
| +3% | +$1.19M |
2015 Q4
3 quarters
|
|
866
State Street SPDR S&P Semiconductor ETF
XSD
$3B
| $45.2M | 0.01% |
850,000
+50,000
| +6% | +$2.47M |
2015 Q1
6 quarters
|
|
867
Dana Inc
DAN
$3.12B
| $45.1M | 0.01% |
2,891,456
+686,895
| +31% | +$9.36M |
2013 Q2
13 quarters
|
|
|
RAD
868
CALL
DELISTED
Rite Aid Corporation
RAD
| $45.1M | 0.01% |
293,015
+243,015
| +486% | +$36.3M |
2016 Q2
1 quarter
|
|
869
Westamerica Bancorp
WABC
$1.37B
| $44.9M | 0.01% |
883,222
+3,316
| +0.4% | +$162K |
2013 Q2
13 quarters
|
|
870
Hope Bancorp
HOPE
$1.72B
| $44.8M | 0.01% |
2,581,337
+1,654,466
| +179% | +$26.8M |
2013 Q2
13 quarters
|
|
|
IM
871
DELISTED
Ingram Micro
IM
| $44.8M | 0.01% |
1,256,217
-95,995
| -7% | -$3.33M |
2013 Q2
13 quarters
|
|
|
BLCM
872
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $44.5M | 0.01% |
223,406
-12,133
| -5% | -$2.09M |
2014 Q4
7 quarters
|
|
|
MXIM
873
DELISTED
Maxim Integrated Products
MXIM
| $44.3M | 0.01% |
1,109,821
+51,233
| +5% | +$2.02M |
2013 Q2
13 quarters
|
|
|
CPHD
874
DELISTED
Cepheid Inc
CPHD
| $44.2M | 0.01% |
839,727
+838,539
| +70,584% | +$33.4M |
2015 Q4
3 quarters
|
|
875
DELISTED
Coresite Realty Corporation
COR
| $43.9M | 0.01% |
592,542
+41,915
| +8% | +$3.4M |
2013 Q2
13 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2016 Portfolio in Review
As of Q3 2016, JP Morgan Chase held 5,175 positions worth $406B, up 1.3% from $401B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase withdrew a net $13.6B in Q3 2016, closing 607 positions and reducing 1,910 holdings. Its most notable exit was COLUMBIA PIPELINE GROUP IN COM STK (DE), an estimated $395M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
Against the trend, JP Morgan Chase opened a new position in Patheon N.V. worth $91.3M.
- JP Morgan Chase's largest Q3 2016 buy was Patheon N.V.: 3,082,044 shares worth $91.3M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $4B increase.
- JP Morgan Chase's biggest Q3 2016 reduction was Xtrackers MSCI EAFE Hedged Equity ETF, cutting an estimated $2.45B.
- JP Morgan Chase fully exited COLUMBIA PIPELINE GROUP IN COM STK (DE) in Q3 2016, selling an estimated $395M.
- JP Morgan Chase's ten largest holdings make up 18% of its $406B portfolio in Q3 2016.
- JP Morgan Chase opened 337 new positions and closed 607 in Q3 2016.
- JP Morgan Chase's portfolio value rose 1.3% quarter-over-quarter to $406B.
Based on JP Morgan Chase's 13F filing for Q3 2016, filed 4 Nov 2016.